Arrayit Corporation (ARYC) 0.0007 $ARYC
Arrayit Corporation Receives Approval for Ten Million Share Dividend in AVDX Stock to ARYC Shareholders
ACCESSWIRE - Mon Dec 07, 10:47AM CST
SUNNYVALE, CA / ACCESSWIRE / December 7, 2015 / Arrayit Corporation (OTC: ARYC), a life sciences company, announces today it has received Financial Industry Regulatory Authority (FINRA) approval to dividend ten million common shares of its ownership in Avant Diagnostics (OTCQB: AVDX) to ARYC common shareholders as of the October 30, 2015 record date. The present market value of the dividend is $2.6 million and there were approximately 450 million ARYC common shares outstanding as of the record date. The dividend will be paid as soon as practicable.
Arrayit Corporation Awards $3M Stock Dividend to ARYC Shareholders
ACCESSWIRE - Wed Sep 30, 2:12PM CDT
SUNNYVALE, CA / ACCESSWIRE / September 30, 2015 / Arrayit Corporation (OTCQB: ARYC), a life sciences company, announces today that the Arrayit Board of Directors has voted unanimously to issue 10,000,000 common shares of its subsidiary Avant Diagnostics (OTCQB: AVDX) to ARYC common shareholders, representing a present market value of approximately 3 million dollars. The 10,000,000 share AVDX dividend will be distributed on a pro rata basis to all ARYC shareholders of record as of the close of market today. Based on the approximately 450,000,000 common shares of ARYC currently issued, ARYC shareholders will receive approximately 0.022 shares of AVDX per share of ARYC. The company expects that the stock certificates can be distributed within approximately four weeks after September 30, 2015, pending regulatory approval of the transaction.
Penny Stocks Reports for TapImmune, Axiom, DRONE AVIATION, TOTALLY HEMP CRAZY, EKSO BIONICS HOLDING, and Arrayit
PR Newswire - Mon Jun 29, 8:00AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TapImmune (OTCMKTS:TPIV), Axiom (OTCMKTS:AXMM), DRONE AVIATION (OTCMKTS
RNE), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), EKSO BIONICS HOLDING (OTCBB:EKSO), and Arrayit (OTCMKTS:ARYC).
Penny Stocks Recap for Propanc Health Group, Arrayit Corp, PositiveID, TapImmune, TOTALLY HEMP CRAZY, and Medican Enterprises
PR Newswire - Fri Jun 19, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Propanc Health Group (OTCMKTS
PCH), Arrayit Corp (OTCMKTS:ARYC), PositiveID (OTCMKTSSID), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), and Medican Enterprises (OTCMKTS:MDCN).
Arrayit Corporation and Vivos Team Up on Global Genome Vault
ACCESSWIRE - Wed May 13, 11:22AM CDT
SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth.
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide
ACCESSWIRE - Thu May 07, 1:28PM CDT
SUNNYVALE, CA / ACCESSWIRE / May 7, 2015 / The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (OTCQB: ARYC) and the United States Department of Agriculture (USDA), "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens," entitles Arrayit to an exclusive license to commercialize the technology.
Arrayit Corporation to Host Fiscal Year 2014 Earnings Conference Call and Webcast Live on Wednesday, April 22, 2015
ACCESSWIRE - Tue Apr 21, 3:29PM CDT
SUNNYVALE, CA / ACCESSWIRE / April 21, 2015 / Arrayit Corporation (OTCQB: ARYC) will host a conference call and live webcast to discuss the results of the fiscal year 2014, to be held Wednesday, April 22, 2015 at 11:00 AM Eastern Time.
Avant Diagnostics, Inc. Begins OvaDx FDA Trials and Engages Clinical Research Organization
BusinessWire - Wed Apr 15, 7:00AM CDT
Avant Diagnostics, Inc. (OTCBB: AVDX) ("Avant"
, a diagnostic company with a primary focus on the commercialization of a proprietary diagnostic test for the early detection of ovarian cancer called OvaDx(R), is pleased to announce that it has engaged the professional services of DOCRO, Inc. ("DOCRO" to manage the preparation and the submission of the pre-submission package for OvaDx(R) and to conduct the negotiation with the U.S. Food and Drug Administration ("FDA" office for the process for obtaining a 510(k) clearance of the OvaDx(R) device intended for use as an aid in monitoring women diagnosed with ovarian cancer. Additionally, Avant purchased the necessary ovarian cancer samples required for the supervised, double blinded clinical validation testing data to be included in the pre-submission package.
Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog
GlobeNewswire - Wed Feb 11, 9:56AM CST
Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces today that the company is debuting major new products and services for the billion dollar genomics and proteomics markets in the company's new full color, image-rich 2015/2016 catalog. Arrayit High-Seq(TM) genomic labeling kits, HuProt(TM) v2.0 19K human proteome microarrays, InnoScan(R) 910 and 1100 microarray scanners, series 3 glass consumables, and TissueMax(TM) personal tissue microarrayers featured in the new catalog are speeding basic research and clinical medicine to improve healthcare, agriculture and food safety.
Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation
GlobeNewswire - Wed Dec 31, 8:00AM CST
Arrayit Corporation (OTCQB:ARYC) announces that its subsidiary Avant Diagnostics, Inc., a medical technology company developing cutting edge medical diagnostic tests, has been acquired by American Liberty Petroleum Corporation (OTCBB:OREO). The board of directors and a majority of shareholders of American Liberty Petroleum Corporation have authorized a number of corporate actions in order to complete the acquisition, including a reverse split, a name change, authorization of Preferred Stock, and filing the required SEC disclosure statements. Upon the effectiveness of these corporate actions, Gregg Linn, Avant's CFO, will join the board of directors of the company as CEO and President.
Arrayit Corporation Signs Cooperative Research and Development Agreement with the United States Department of Agriculture
ACCESSWIRE - Wed Dec 10, 7:03AM CST
Sunnyvale, CA / ACCESSWIRE / December 10, 2014 / Arrayit Corporation (ARYC) announces that it has signed a Cooperative Research and Development Agreement (CRADA) with the United States Department of Agriculture (USDA) entitled "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens." Under the terms of the agreement, Arrayit and the USDA Agricultural Research Service (USDA ARS) will develop and validate a rapid, portable, cost-effective and high-throughput detection system for the surveillance of multiple bacterial and viral foodborne pathogens including hepatitis, E. coli, Salmonella, Listeria, Campylobacter and Norovirus. The expected outcome is a commercial test that will be widely deployed throughout the lifecycle of food production and distribution to ensure that our food supply is safe for consumption.
Arrayit Corporation to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Wednesday, November 26, 2014
ACCESSWIRE - Tue Nov 25, 11:43AM CST
Sunnyvale, CA / ACCESSWIRE / November 25, 2014 / Arrayit Corporation (OTCQB:ARYC) will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Wednesday, November 26, 2014 at 11:00 AM Eastern Time.
Arrayit Corporation Receives Approval for Ten Million Share Dividend in AVDX Stock to ARYC Shareholders
ACCESSWIRE - Mon Dec 07, 10:47AM CST
SUNNYVALE, CA / ACCESSWIRE / December 7, 2015 / Arrayit Corporation (OTC: ARYC), a life sciences company, announces today it has received Financial Industry Regulatory Authority (FINRA) approval to dividend ten million common shares of its ownership in Avant Diagnostics (OTCQB: AVDX) to ARYC common shareholders as of the October 30, 2015 record date. The present market value of the dividend is $2.6 million and there were approximately 450 million ARYC common shares outstanding as of the record date. The dividend will be paid as soon as practicable.
Arrayit Corporation Awards $3M Stock Dividend to ARYC Shareholders
ACCESSWIRE - Wed Sep 30, 2:12PM CDT
SUNNYVALE, CA / ACCESSWIRE / September 30, 2015 / Arrayit Corporation (OTCQB: ARYC), a life sciences company, announces today that the Arrayit Board of Directors has voted unanimously to issue 10,000,000 common shares of its subsidiary Avant Diagnostics (OTCQB: AVDX) to ARYC common shareholders, representing a present market value of approximately 3 million dollars. The 10,000,000 share AVDX dividend will be distributed on a pro rata basis to all ARYC shareholders of record as of the close of market today. Based on the approximately 450,000,000 common shares of ARYC currently issued, ARYC shareholders will receive approximately 0.022 shares of AVDX per share of ARYC. The company expects that the stock certificates can be distributed within approximately four weeks after September 30, 2015, pending regulatory approval of the transaction.
Penny Stocks Reports for TapImmune, Axiom, DRONE AVIATION, TOTALLY HEMP CRAZY, EKSO BIONICS HOLDING, and Arrayit
PR Newswire - Mon Jun 29, 8:00AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TapImmune (OTCMKTS:TPIV), Axiom (OTCMKTS:AXMM), DRONE AVIATION (OTCMKTS
RNE), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), EKSO BIONICS HOLDING (OTCBB:EKSO), and Arrayit (OTCMKTS:ARYC). Penny Stocks Recap for Propanc Health Group, Arrayit Corp, PositiveID, TapImmune, TOTALLY HEMP CRAZY, and Medican Enterprises
PR Newswire - Fri Jun 19, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Propanc Health Group (OTCMKTS
PCH), Arrayit Corp (OTCMKTS:ARYC), PositiveID (OTCMKTSSID), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), and Medican Enterprises (OTCMKTS:MDCN). Arrayit Corporation and Vivos Team Up on Global Genome Vault
ACCESSWIRE - Wed May 13, 11:22AM CDT
SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth.
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide
ACCESSWIRE - Thu May 07, 1:28PM CDT
SUNNYVALE, CA / ACCESSWIRE / May 7, 2015 / The ongoing Cooperative Research and Development Agreement (CRADA) between Arrayit Corporation (OTCQB: ARYC) and the United States Department of Agriculture (USDA), "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens," entitles Arrayit to an exclusive license to commercialize the technology.
Arrayit Corporation to Host Fiscal Year 2014 Earnings Conference Call and Webcast Live on Wednesday, April 22, 2015
ACCESSWIRE - Tue Apr 21, 3:29PM CDT
SUNNYVALE, CA / ACCESSWIRE / April 21, 2015 / Arrayit Corporation (OTCQB: ARYC) will host a conference call and live webcast to discuss the results of the fiscal year 2014, to be held Wednesday, April 22, 2015 at 11:00 AM Eastern Time.
Avant Diagnostics, Inc. Begins OvaDx FDA Trials and Engages Clinical Research Organization
BusinessWire - Wed Apr 15, 7:00AM CDT
Avant Diagnostics, Inc. (OTCBB: AVDX) ("Avant"
, a diagnostic company with a primary focus on the commercialization of a proprietary diagnostic test for the early detection of ovarian cancer called OvaDx(R), is pleased to announce that it has engaged the professional services of DOCRO, Inc. ("DOCRO" to manage the preparation and the submission of the pre-submission package for OvaDx(R) and to conduct the negotiation with the U.S. Food and Drug Administration ("FDA" office for the process for obtaining a 510(k) clearance of the OvaDx(R) device intended for use as an aid in monitoring women diagnosed with ovarian cancer. Additionally, Avant purchased the necessary ovarian cancer samples required for the supervised, double blinded clinical validation testing data to be included in the pre-submission package. Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog
GlobeNewswire - Wed Feb 11, 9:56AM CST
Arrayit Corporation (OTCQB:ARYC), a life sciences and molecular diagnostics leader, announces today that the company is debuting major new products and services for the billion dollar genomics and proteomics markets in the company's new full color, image-rich 2015/2016 catalog. Arrayit High-Seq(TM) genomic labeling kits, HuProt(TM) v2.0 19K human proteome microarrays, InnoScan(R) 910 and 1100 microarray scanners, series 3 glass consumables, and TissueMax(TM) personal tissue microarrayers featured in the new catalog are speeding basic research and clinical medicine to improve healthcare, agriculture and food safety.
Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation
GlobeNewswire - Wed Dec 31, 8:00AM CST
Arrayit Corporation (OTCQB:ARYC) announces that its subsidiary Avant Diagnostics, Inc., a medical technology company developing cutting edge medical diagnostic tests, has been acquired by American Liberty Petroleum Corporation (OTCBB:OREO). The board of directors and a majority of shareholders of American Liberty Petroleum Corporation have authorized a number of corporate actions in order to complete the acquisition, including a reverse split, a name change, authorization of Preferred Stock, and filing the required SEC disclosure statements. Upon the effectiveness of these corporate actions, Gregg Linn, Avant's CFO, will join the board of directors of the company as CEO and President.
Arrayit Corporation Signs Cooperative Research and Development Agreement with the United States Department of Agriculture
ACCESSWIRE - Wed Dec 10, 7:03AM CST
Sunnyvale, CA / ACCESSWIRE / December 10, 2014 / Arrayit Corporation (ARYC) announces that it has signed a Cooperative Research and Development Agreement (CRADA) with the United States Department of Agriculture (USDA) entitled "Rapid and Cost Effective Detection Technologies for Noroviruses and other Foodborne Pathogens." Under the terms of the agreement, Arrayit and the USDA Agricultural Research Service (USDA ARS) will develop and validate a rapid, portable, cost-effective and high-throughput detection system for the surveillance of multiple bacterial and viral foodborne pathogens including hepatitis, E. coli, Salmonella, Listeria, Campylobacter and Norovirus. The expected outcome is a commercial test that will be widely deployed throughout the lifecycle of food production and distribution to ensure that our food supply is safe for consumption.
Arrayit Corporation to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Wednesday, November 26, 2014
ACCESSWIRE - Tue Nov 25, 11:43AM CST
Sunnyvale, CA / ACCESSWIRE / November 25, 2014 / Arrayit Corporation (OTCQB:ARYC) will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Wednesday, November 26, 2014 at 11:00 AM Eastern Time.
